Lv3
288 积分 2021-11-19 加入
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer
8天前
已完结
PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)
8天前
已完结
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade
1个月前
已完结
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer
1个月前
已完结
Chinese Immune Multi-Omics Atlas
1个月前
已完结
Liquid biopsies across the cancer care continuum
1个月前
已完结
Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunity
1个月前
已完结
Foritinib, a type II ROS1 inhibitor for NSCLC
1个月前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
3个月前
已完结
MA15.01 Strong PD-L1 Expression Predicts Poor Response and de Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients with EGFR Mutation
3个月前
已完结
皖公网安备34019202002308
